A single-center experience with intracardiac thrombosis in children with dilated cardiomyopathy

Soo-Han Choi1, Soo In Jeong, Ji-Hyuk Yang

  • 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea.

Pediatric Cardiology
|November 26, 2009
PubMed

Insights

Intracardiac thrombosis occurs in 6% of children with dilated cardiomyopathy, often during rapid ventricular dysfunction. Early anticoagulation is crucial for preventing serious complications in these high-risk pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Hematology

Background:

  • Dilated cardiomyopathy in children poses significant risks.
  • Intracardiac thrombosis is a life-threatening complication associated with this condition.

Purpose of the Study:

  • To determine the incidence, risk factors, and outcomes of intracardiac thrombosis in pediatric patients with dilated cardiomyopathy.
  • To highlight the importance of early detection and management.

Main Methods:

  • Retrospective review of clinical records of 83 children diagnosed with dilated cardiomyopathy between 1995 and 2008.
  • Analysis of patient data to identify thrombus formation, location, and associated clinical factors.

Main Results:

  • Intracardiac thrombi were identified in 5 patients (6.0%).
  • Thrombi were predominantly located in the left ventricle, associated with poor ejection fraction and rapid ventricular function deterioration.
  • All patients received heparinization; one underwent thrombectomy, with three achieving complete resolution.

Conclusions:

  • Intracardiac thrombosis is a notable complication in children with dilated cardiomyopathy, particularly those with impaired ventricular function.
  • Aggressive anticoagulation and vigilant monitoring are essential for preventing embolic events and managing intracardiac thrombosis in this vulnerable population.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...